Dr. David Bruyette comments on the latest developments in treating canine PDH and whether or not pituitary surgery will take the place of medical therapy.
David S. Bruyette, DVM, DACVIM, comments on the latest developments in treating pituitary-dependent hyperadrenocorticism in dogs and whether or not pituitary surgery will take the place of medical therapy.
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.